Aura Biosciences SG&A Expense (Semi Annual) Insights

Aura Biosciences, Inc. (AURA)

6.66 +0.12 (+1.83%) USD | NASDAQ | Apr 06, 09:34

View SG&A Expense (Semi Annual) for AURA.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (Semi Annual) Chart

Start Trial

View Historical Data

Start Trial

View SG&A Expense (Semi Annual) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View SG&A Expense (Semi Annual) Benchmarks

Start Trial

Assertio Holdings, Inc.	--
Olema Pharmaceuticals, Inc.	--
Elicio Therapeutics, Inc.	--
ACADIA Pharmaceuticals, Inc.	--
Alnylam Pharmaceuticals, Inc.	--